Key result
Aldosterone/salt treatment induced early and persistent intracellular calcium and zinc overloading in cardiac myocytes and mitochondria, leading to oxidative stress that overwhelmed antioxidant defenses.
Aldosteronism induces early, coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria, initially counterbalanced by antioxidant defenses that are ultimately overwhelmed by week 4, leading to oxidative stress and cell damage.
Suggests mechanistic pathway in experimental aldosteronism; hypothesis-generating and should not yet change practice.
Intracellular Ca(2+) overloading, coupled to induction of oxidative stress, is present at 4-wk aldosterone/salt treatment (ALDOST). This prooxidant reaction in cardiac myocytes and mitochondria accounts for necrotic cell death and subsequent myocardial scarring. It is intrinsically linked to increased intracellular zinc concentration ([Zn(2+)](i)) serving as an antioxidant. Herein, we addressed the temporal responses in coupled Ca(2+) and Zn(2+) dyshomeostasis, reflecting the prooxidant-antioxidant equilibrium, by examining preclinical (week 1) and pathological (week 4) stages of ALDOST to determine whether endogenous antioxidant defenses would be ultimately overwhelmed to account for this delay in cardiac remodeling. We compared responses in cardiomyocyte free [Ca(2+)](i) and [Zn(2+)](i) and mitochondrial total [Ca(2+)](m) and [Zn(2+)](m), together with biomarkers of oxidative stress and antioxidant defenses, during 1- and 4-wk ALDOST. At week 1 and compared with controls, we found: 1) elevations in [Ca(2+)](i) and [Ca(2+)](m) were coupled with [Zn(2+)](i) and [Zn(2+)](m); 2) increased mitochondrial H(2)O(2) production, cardiomyocyte xanthine oxidase activity, and cardiac and mitochondrial 8-isoprostane levels, counterbalanced by increased activity of antioxidant proteins, enzymes, and the nonenzymatic antioxidants that can be considered as cumulative antioxidant capacity; some of these enzymes and proteins (e.g., metallothionein-1, Cu/Zn-superoxide, glutathione synthase) are regulated by metal-responsive transcription factor-1; and 3) although these augmented antioxidant defenses were sustained at week 4, they fell short in combating the persistent intracellular Ca(2+) overloading and marked rise in cardiac tissue 8-isoprostane and mitochondrial transition pore opening. Thus a coupled Ca(2+) and Zn(2+) dyshomeostasis occurs early during ALDOST in cardiac myocytes and mitochondria that regulate redox equilibrium until week 4 when ongoing intracellular Ca(2+) overloading and prooxidants overwhelm antioxidant defenses.
No takes yet. Share an insight, caveat, or question.
Kamalov et al. (2009) studied Aldosteronism. Aldosterone/salt treatment (ALDOST) vs. Unoperated, untreated age-/sex-matched rats was evaluated on Cytosolic free [Ca2+]i in cardiomyocytes at week 4 (p=<0.05). Aldosterone/salt treatment induced early and persistent intracellular calcium and zinc overloading in cardiac myocytes and mitochondria, leading to oxidative stress that overwhelmed antioxidant defenses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: